Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain. Gabapentin was originally marketed under the brand name Neurontin and since it became generic, it has been marketed under many other brand names. An extended-release formulation of gabapentin for once-daily administration was introduced in 2011 for postherpetic neuralgia under the brand name Gralise. Gabapentin is used primarily to treat seizures and neuropathic pain. It is also commonly prescribed for many off-label uses, such as treatment of anxiety disorders, insomnia, and bipolar disorder. There are, however, concerns regarding the quality of the trials conducted and evidence for some such uses, especially in the case of its use as a mood stabilizer in bipolar disorder.
This report elaborates on the current development of the Gabapentin industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Aurobindo Pharma
Marksans Pharma
Apotex
Mylan
Sun Pharmaceutical
Alkem
Novartis
TEVA
Jiangsu Enhua
Assertio Therapeutics
Amneal
Arbor Pharma
Glenmark
By Type:
Tablet
Capsule
By Application:
Restless Legs Syndrome
Others
Epilepsy
Neuropathic Pain
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Gabapentin Market Overview 2018-2029
-
1.1 China Gabapentin Industry Development Overview
-
1.2 China Gabapentin Industry Development History
-
1.3 China Gabapentin Industry Market Size (2018-2029)
-
1.4 China Gabapentin Market Analysis by Type from Production Side
-
1.4.1 China Gabapentin Production Volume, Production Value and Growth Rate of Tablet (2018-2029)
-
1.4.2 China Gabapentin Production Volume, Production Value and Growth Rate of Capsule (2018-2029)
-
1.5 China Gabapentin Market Analysis by Application from Consumption End
-
1.5.1 China Gabapentin Sales Volume, Sales Value and Growth Rate of Restless Legs Syndrome (2018-2029)
-
1.5.2 China Gabapentin Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.3 China Gabapentin Sales Volume, Sales Value and Growth Rate of Epilepsy (2018-2029)
-
1.5.4 China Gabapentin Sales Volume, Sales Value and Growth Rate of Neuropathic Pain (2018-2029)
-
1.6 China Gabapentin Market Analysis by Region
-
1.6.1 North China Gabapentin Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Gabapentin Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Gabapentin Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Gabapentin Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Gabapentin Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Gabapentin Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Gabapentin Market Size and Growth Rate from 2018-2029
Chapter 2 China Gabapentin Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Gabapentin Market Status and Competition at home and abroad in 2023
-
2.2.2 China Gabapentin Market Status and Competition Analysis in 2023
-
2.2.3 China Gabapentin Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Gabapentin Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Gabapentin Industry Development
Chapter 3 GabapentinIndustry Chain Analysis
-
3.1 Gabapentin Industry Chain
-
3.2 Gabapentin Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Gabapentin Market
-
3.3 Gabapentin Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Gabapentin Market
Chapter 4 China Gabapentin Market, by Type
-
4.1 China Gabapentin Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Gabapentin Total Production Volume and Growth Rate from Production Side
-
4.5 China Gabapentin Production Volume and Growth Rate, by Type
-
4.5.1 China Gabapentin Production Volume and Growth Rate of Tablet
-
4.5.2 China Gabapentin Production Volume and Growth Rate of Capsule
Chapter 5 China Gabapentin Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Gabapentin Total Market Size and Growth Rate from Consumption End
-
5.5 China Gabapentin Market Size and Growth Rate, by Application
-
5.5.1 China Gabapentin Market Size and Growth Rate of Restless Legs Syndrome
-
5.5.2 China Gabapentin Market Size and Growth Rate of Others
-
5.5.3 China Gabapentin Market Size and Growth Rate of Epilepsy
-
5.5.4 China Gabapentin Market Size and Growth Rate of Neuropathic Pain
Chapter 6 China Gabapentin Market, by Region
-
6.1 China Gabapentin Production Volume and Production Value, by Region
-
6.2 China Gabapentin Sales Volume and Sales Value, by Region
Chapter 7 North China Gabapentin Market Analysis
-
7.1 North China Gabapentin Market, by Type
-
7.2 North China Gabapentin Market, by Application
Chapter 8 Central China Gabapentin Market Analysis
-
8.1 Central China Gabapentin Market, by Type
-
8.2 Central China Gabapentin Market, by Application
Chapter 9 South China Gabapentin Market Analysis
-
9.1 South China Gabapentin Market, by Type
-
9.2 South China Gabapentin Market, by Application
Chapter 10 East China Gabapentin Market Analysis
-
10.1 East China Gabapentin Market, by Type
-
10.2 East China Gabapentin Market, by Application
Chapter 11 Northeast China Gabapentin Market Analysis
-
11.1 Northeast China Gabapentin Market, by Type
-
11.2 Northeast China Gabapentin Market, by Application
Chapter 12 Southwest China Gabapentin Market Analysis
-
12.1 Southwest China Gabapentin Market, by Type
-
12.2 Southwest China Gabapentin Market, by Application
Chapter 13 Northwest China Gabapentin Market Analysis
-
13.1 Northwest China Gabapentin Market, by Type
-
13.2 Northwest China Gabapentin Market, by Application
Chapter 14 Company Profiles
-
14.1 Aurobindo Pharma
-
14.1.1 Aurobindo Pharma Company Profile
-
14.1.2 Aurobindo Pharma Gabapentin Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Marksans Pharma
-
14.2.1 Marksans Pharma Company Profile
-
14.2.2 Marksans Pharma Gabapentin Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Apotex
-
14.3.1 Apotex Company Profile
-
14.3.2 Apotex Gabapentin Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Mylan
-
14.4.1 Mylan Company Profile
-
14.4.2 Mylan Gabapentin Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Sun Pharmaceutical
-
14.5.1 Sun Pharmaceutical Company Profile
-
14.5.2 Sun Pharmaceutical Gabapentin Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Alkem
-
14.6.1 Alkem Company Profile
-
14.6.2 Alkem Gabapentin Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Novartis
-
14.7.1 Novartis Company Profile
-
14.7.2 Novartis Gabapentin Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 TEVA
-
14.8.1 TEVA Company Profile
-
14.8.2 TEVA Gabapentin Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Jiangsu Enhua
-
14.9.1 Jiangsu Enhua Company Profile
-
14.9.2 Jiangsu Enhua Gabapentin Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Assertio Therapeutics
-
14.10.1 Assertio Therapeutics Company Profile
-
14.10.2 Assertio Therapeutics Gabapentin Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Amneal
-
14.11.1 Amneal Company Profile
-
14.11.2 Amneal Gabapentin Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Arbor Pharma
-
14.12.1 Arbor Pharma Company Profile
-
14.12.2 Arbor Pharma Gabapentin Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Glenmark
-
14.13.1 Glenmark Company Profile
-
14.13.2 Glenmark Gabapentin Market Performance
-
14.13.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Gabapentin Industry Research Conclusions
-
15.2 Gabapentin Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Gabapentin Industry Market Size (2018-2029)
-
Figure China Gabapentin Production Volume, Production Value and Growth Rate of Tablet (2018-2029)
-
Figure China Gabapentin Production Volume, Production Value and Growth Rate of Capsule (2018-2029)
-
Figure China Gabapentin Sales Volume, Sales Value and Growth Rate of Restless Legs Syndrome (2018-2029)
-
Figure China Gabapentin Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Gabapentin Sales Volume, Sales Value and Growth Rate of Epilepsy (2018-2029)
-
Figure China Gabapentin Sales Volume, Sales Value and Growth Rate of Neuropathic Pain (2018-2029)
-
Figure North China Gabapentin Market Size and Growth Rate from 2018-2029
-
Figure Central China Gabapentin Market Size and Growth Rate from 2018-2029
-
Figure South China Gabapentin Market Size and Growth Rate from 2018-2029
-
Figure East China Gabapentin Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Gabapentin Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Gabapentin Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Gabapentin Market Size and Growth Rate from 2018-2029
-
Figure Gabapentin Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Gabapentin Market Share by Type in 2018
-
Figure China Gabapentin Market Share by Type in 2023
-
Figure China Gabapentin Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Gabapentin Production Volume and Growth Rate of Tablet (2018-2023)
-
Figure China Gabapentin Production Volume and Growth Rate of Capsule (2018-2023)
-
Figure China Gabapentin Market Share by Application in 2018
-
Figure China Gabapentin Market Share by Application in 2023
-
Figure China Gabapentin Total Market Size and Growth Rate from Consumption End
-
Figure China Gabapentin Market Size and Growth Rate of Restless Legs Syndrome (2018-2023)
-
Figure China Gabapentin Market Size and Growth Rate of Others (2018-2023)
-
Figure China Gabapentin Market Size and Growth Rate of Epilepsy (2018-2023)
-
Figure China Gabapentin Market Size and Growth Rate of Neuropathic Pain (2018-2023)
-
Table China Gabapentin Production Volume by Region (2018-2023)
-
Table China Gabapentin Production Volume Share by Region (2018-2023)
-
Figure China Gabapentin Production Volume Share by Region (2018-2023)
-
Table China Gabapentin Production Value by Region (2018-2023)
-
Table China Gabapentin Production Value Share by Region (2018-2023)
-
Figure China Gabapentin Production Value Share by Region (2018-2023)
-
Table China Gabapentin Sales Volume by Region (2018-2023)
-
Table China Gabapentin Sales Volume Share by Region (2018-2023)
-
Figure China Gabapentin Sales Volume Share by Region (2018-2023)
-
Table China Gabapentin Sales Value by Region (2018-2023)
-
Table China Gabapentin Sales Value Share by Region (2018-2023)
-
Figure China Gabapentin Sales Value Share by Region (2018-2023)
-
Table North China Gabapentin Production Volume by Type (2018-2023)
-
Table North China Gabapentin Production Volume Share by Type (2018-2023)
-
Figure North China Gabapentin Production Volume Share by Type (2018-2023)
-
Table North China Gabapentin Sales Volume by Application (2018-2023)
-
Table North China Gabapentin Sales Volume Share by Application (2018-2023)
-
Figure North China Gabapentin Sales Volume Share by Application (2018-2023)
-
Table Central China Gabapentin Production Volume by Type (2018-2023)
-
Table Central China Gabapentin Production Volume Share by Type (2018-2023)
-
Figure Central China Gabapentin Production Volume Share by Type (2018-2023)
-
Table Central China Gabapentin Sales Volume by Application (2018-2023)
-
Table Central China Gabapentin Sales Volume Share by Application (2018-2023)
-
Figure Central China Gabapentin Sales Volume Share by Application (2018-2023)
-
Table South China Gabapentin Production Volume by Type (2018-2023)
-
Table South China Gabapentin Production Volume Share by Type (2018-2023)
-
Figure South China Gabapentin Production Volume Share by Type (2018-2023)
-
Table South China Gabapentin Sales Volume by Application (2018-2023)
-
Table South China Gabapentin Sales Volume Share by Application (2018-2023)
-
Figure South China Gabapentin Sales Volume Share by Application (2018-2023)
-
Table East China Gabapentin Production Volume by Type (2018-2023)
-
Table East China Gabapentin Production Volume Share by Type (2018-2023)
-
Figure East China Gabapentin Production Volume Share by Type (2018-2023)
-
Table East China Gabapentin Sales Volume by Application (2018-2023)
-
Table East China Gabapentin Sales Volume Share by Application (2018-2023)
-
Figure East China Gabapentin Sales Volume Share by Application (2018-2023)
-
Table Northeast China Gabapentin Production Volume by Type (2018-2023)
-
Table Northeast China Gabapentin Production Volume Share by Type (2018-2023)
-
Figure Northeast China Gabapentin Production Volume Share by Type (2018-2023)
-
Table Northeast China Gabapentin Sales Volume by Application (2018-2023)
-
Table Northeast China Gabapentin Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Gabapentin Sales Volume Share by Application (2018-2023)
-
Table Southwest China Gabapentin Production Volume by Type (2018-2023)
-
Table Southwest China Gabapentin Production Volume Share by Type (2018-2023)
-
Figure Southwest China Gabapentin Production Volume Share by Type (2018-2023)
-
Table Southwest China Gabapentin Sales Volume by Application (2018-2023)
-
Table Southwest China Gabapentin Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Gabapentin Sales Volume Share by Application (2018-2023)
-
Table Northwest China Gabapentin Production Volume by Type (2018-2023)
-
Table Northwest China Gabapentin Production Volume Share by Type (2018-2023)
-
Figure Northwest China Gabapentin Production Volume Share by Type (2018-2023)
-
Table Northwest China Gabapentin Sales Volume by Application (2018-2023)
-
Table Northwest China Gabapentin Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Gabapentin Sales Volume Share by Application (2018-2023)
-
Table Aurobindo Pharma Company Profile
-
Table Aurobindo Pharma Gabapentin Revenue, Price and Gross (2018-2023)
-
Table Marksans Pharma Company Profile
-
Table Marksans Pharma Gabapentin Revenue, Price and Gross (2018-2023)
-
Table Apotex Company Profile
-
Table Apotex Gabapentin Revenue, Price and Gross (2018-2023)
-
Table Mylan Company Profile
-
Table Mylan Gabapentin Revenue, Price and Gross (2018-2023)
-
Table Sun Pharmaceutical Company Profile
-
Table Sun Pharmaceutical Gabapentin Revenue, Price and Gross (2018-2023)
-
Table Alkem Company Profile
-
Table Alkem Gabapentin Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Gabapentin Revenue, Price and Gross (2018-2023)
-
Table TEVA Company Profile
-
Table TEVA Gabapentin Revenue, Price and Gross (2018-2023)
-
Table Jiangsu Enhua Company Profile
-
Table Jiangsu Enhua Gabapentin Revenue, Price and Gross (2018-2023)
-
Table Assertio Therapeutics Company Profile
-
Table Assertio Therapeutics Gabapentin Revenue, Price and Gross (2018-2023)
-
Table Amneal Company Profile
-
Table Amneal Gabapentin Revenue, Price and Gross (2018-2023)
-
Table Arbor Pharma Company Profile
-
Table Arbor Pharma Gabapentin Revenue, Price and Gross (2018-2023)
-
Table Glenmark Company Profile
-
Table Glenmark Gabapentin Revenue, Price and Gross (2018-2023)
-
